Celldex Therapeutics, Inc. (CLDX)

NASDAQ: CLDX · IEX Real-Time Price · USD

37.01

-1.98 (-5.08%)

At close: Jul 2, 2024, 4:00 PM

37.17

+0.16 (0.43%)

After-hours: Jul 2, 2024, 5:41 PM EDT

Celldex Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018 - 1994
Net Income	-141.43	-112.33	-70.51	-59.78	-50.88	Upgrade
Depreciation & Amortization	3.01	2.9	3.07	3.93	4.86	Upgrade
Share-Based Compensation	23.89	15.61	8.95	3.92	4.55	Upgrade
Other Operating Activities	7.24	-9.91	-2.42	11.53	-4.95	Upgrade
Operating Cash Flow	-107.29	-103.73	-60.91	-40.4	-46.42	Upgrade
Capital Expenditures	-1.82	-1.76	-1.22	-1.5	-0.71	Upgrade
Change in Investments	-103.96	91.7	-214.93	-96.72	17.79	Upgrade
Investing Cash Flow	-105.78	89.94	-216.16	-98.22	17.08	Upgrade
Share Issuance / Repurchase	218.46	4.08	272.37	171.23	16.26	Upgrade
Financing Cash Flow	218.46	4.08	272.37	171.23	16.26	Upgrade
Net Cash Flow	5.39	-9.71	-4.69	32.6	-13.08	Upgrade
Free Cash Flow	-109.11	-105.49	-62.13	-41.9	-47.13	Upgrade
Free Cash Flow Margin	-1585.20%	-4475.65%	-1335.86%	-564.86%	-1318.95%	Upgrade
Free Cash Flow Per Share	-2.25	-2.25	-1.45	-1.41	-3.25	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).